Home » Topics » BioWorld Science

BioWorld Science
RSS

Abcentra studies orticumab in subjects with psoriasis and cardiometabolic risk factors

Aug. 3, 2021

Collagenase clostridium histolyticum improves foot function in plantar fibromatosis study

Aug. 3, 2021

China's NMPA approves INDs for IASO's CD19/CD22 CAR-T therapy

Aug. 3, 2021

Gem gene sparkles as ischemic stroke drug discovery target

Aug. 3, 2021

Phase II data show safety and efficacy of OCS-02 in dry eye disease

Aug. 3, 2021

Discovery of SR-42667: a tau-SH3 interaction inhibitor that prevents Abeta toxicity

Aug. 3, 2021

Prometheus initiates phase IIa APOLLO-CD study of PRA-023 in Crohn's disease

Aug. 3, 2021

Dosing begins in phase I study of mRNA-6231

Aug. 3, 2021

FDA clears IND for phase I/II MARINA study of AOC-1001

Aug. 3, 2021

Ascentage Pharma discovers mutant GTPase KRAS inhibitors

Aug. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...